Clinical trial
Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects: A Single-dose and Two-period Crossover Study
NCT04411875 is registered in ClinicalTrials.gov with The Affiliated Hospital of Qingdao University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects: A Single-dose and Two-period Crossover Study
- Lead sponsor
- The Affiliated Hospital of Qingdao University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 13, 2018
- Completion date
- February 15, 2019
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy subjects